Management and Treatment of Interstitial Lung Disease in Breast Cancer
January 8th 2020Madelaine Kuiper, MSN, RN, discusses the adverse event of interstitial lung disease, which can occur in patients with HER2-positive metastatic breast cancer who have received fam-trastuzumab deruxtecan-nxki.
Read More